The transcriptional program following p53 activation

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 65, Issue , 2000, Pages 475-482

  Zhao, R ^a   Gish, K ^d   Murphy, M ^d   Yin, Y ^b   Notterman, D ^a   Hoffman, W H ^d   Tom, E ^d   Mack, D H ^d   Levine, A J ^c  

^a PRINCETON UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; OLIGONUCLEOTIDE; TUMOR PROTEIN;

CANCER; CARCINOGENESIS; CELL CYCLE; CONFERENCE PAPER; DNA DAMAGE; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ARTICLE; CANCER CELL; CLUSTER ANALYSIS; COLON CANCER; DNA MICROARRAY; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENETIC SCREENING; TRANSCRIPTION INITIATION; ULTRAVIOLET IRRADIATION; CELL CULTURE; COLON TUMOR; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; TUMOR SUPPRESSOR GENE;

COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMAN; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034437675     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2000.65.475     Document Type: Conference Paper

References (38)

1. Enhanced phosphorylation of p53 by ATM in response to DNA damage
2. Mutational spectra and immunohistochemical analyses of p53 in human cancers
3. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer
4. Induction of the growth inhibitor IGF-binding protein 3 by p53
5. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
6. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53
7. Cluster analysis and display of genome-wide expression patterns
8. The p53 proto-oncogene can act as a suppressor of transformation
9. Changes in keratin gene expression during terminal differentiation of the keratinocyte
10. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
11. Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition
12. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression
13. p53 mutations in human cancers
14. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
15. ATM associates with and phosphorylates p53: Mapping the region of interaction
16. Stress-induced secretion of growth inhibitors: A novel tumor suppressor function of p53
17. p53, the cellular gatekeeper for growth and division
18. MyD genes in negative growth control
19. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein
20. Expression monitoring by hybridization to high-density oligonucleotide arrays
21. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease
22. Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389
23. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
24. The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells
25. Light-directed synthesis of high-density oligonucleotide arrays using semiconductor photoresists
26. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
27. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: A proposed mechanism for bystander effect
28. A model for p53-induced apoptosis
29. The p53 pathway
30. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer
31. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line
32. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites
33. A human gene encoding a putative basic helix-loop-helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells
34. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene
35. Genome-wide expression monitoring in Saccharomyces cerevisiae
36. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
37. Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity
38. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays